テニスのスター、イガ・シフィアテクが禁止薬物検査で陽性反応が出て１か月の出場停止処分を受け入れる

グランドスラム大会で5度優勝したイガ・シフィアテクは、禁止薬物の検査で陽性反応が出たため、1か月の出場停止処分を受け入れた。

Five-time Grand Slam champion Iga Swiatek has accepted a one-month suspension after she tested positive for a banned substance. The tennis ace had tested positive for a heart medicine called trimetazidine or TMZ. She failed an out of competition drug test in August.

Iga Swiatek suspended for one month in doping case

Earlier, the ITIA accepted Iga Swiatek’s explanation for testing positive for the banned substance. She claimed that the result of the test was unintentional and was caused by the contamination of a nonprescription medication, melatonin which took to deal with jet lag and sleeping. It was determined her level of fault was “at the lowest end of the range for no significant fault or negligence,” the IATA said.

Wow.

The ITIA announces that Iga Świątek has accepted a 1-month suspension after testing positive for the prohibited substance trimetazidine (TMZ) in an out-of-competition sample in August 2024.

ITIA investigation determines source was a contaminated regulated medication which… pic.twitter.com/cBJPkU2CBs

— José Morgado (@josemorgado) November 28, 2024

Latest news

While Iga Swiatek has established herself as the queen of clay, questions remain about her performance on other surfaces.

With 106 weeks at the No. 1 ranking, she is already one of the most dominant players of her generation. However, further success at Grand Slams on grass and hard courts will solidify her legacy as a truly all-surface champion.

Her aggressive style, unwavering spirit, and relentless pursuit of victory have earned her a place among the legends of Roland Garros. As she sets her sights on further Grand Slam glory, the tennis world waits to see if she can conquer all surfaces, cementing her legacy as one of the game’s all-time greats.